Truscreen Group (ASX:TRU) Common Stock : A$35.58 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Truscreen Group Common Stock?

Truscreen Group's quarterly common stock increased from Sep. 2023 (A$33.31 Mil) to Mar. 2024 (A$35.90 Mil) but then declined from Mar. 2024 (A$35.90 Mil) to Sep. 2024 (A$35.58 Mil).

Truscreen Group's annual common stock increased from Mar. 2022 (A$32.18 Mil) to Mar. 2023 (A$33.57 Mil) and increased from Mar. 2023 (A$33.57 Mil) to Mar. 2024 (A$35.90 Mil).

Truscreen Group Common Stock Historical Data

The historical data trend for Truscreen Group's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Truscreen Group Common Stock Chart

Truscreen Group Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Common Stock

Get a 7-Day Free Trial

26.78

31.99

32.18

33.57

35.90

Truscreen Group Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Common Stock	Get a 7-Day Free Trial															30.65	33.57	33.31	35.90	35.58

Truscreen Group Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Truscreen Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Truscreen Group Ltd (ASX:TRU) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

TRU:New Zealand

Address

C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010

Website

https://www.truscreen.com

Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening system which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.